Supernus Pharmaceuticals ...

NASDAQ: SUPN · Real-Time Price · USD
42.49
0.32 (0.76%)
At close: Aug 15, 2025, 9:54 AM

Supernus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
73.86M 1.32M 60.71M 53.42M
Depreciation & Amortization
80.41M 84.86M 85.54M 32.59M
Stock-Based Compensation
27.75M 26.76M 17.57M 17.91M
Other Working Capital
-4.92M 2.27M 29.14M -3.9M
Other Non-Cash Items
12.11M 33M 3.57M 24.62M
Deferred Income Tax
-20.14M -25.71M -26.32M -4.99M
Change in Working Capital
-2.05M -9.14M -24.24M 3.57M
Operating Cash Flow
171.95M 111.08M 116.83M 127.13M
Capital Expenditures
-725K -551K -412K -2.04M
Cash Acquisitions
n/a n/a -14K -311.69M
Purchase of Investments
-688.01M -101.62M -406.99M -311.57M
Sales Maturities Of Investments
498.86M 370.9M 190.74M 530.51M
Other Investing Acitivies
9K n/a 14K 12.89M
Investing Cash Flow
-189.87M 268.73M -216.66M -81.91M
Debt Repayment
n/a -402.5M n/a -137.51M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.71M -1.99M -22.9M n/a
Financial Cash Flow
12.19M -397.88M -10.48M -130.42M
Net Cash Flow
-5.72M -18.07M -110.31M -85.21M
Free Cash Flow
171.23M 110.53M 116.41M 125.08M